- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-tetramer
- Ligands
- 8 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- FUL: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-FUL.2: 5 residues within 4Å:- Chain A: N.65, W.356, I.388
- Chain B: N.382, F.385
2 PLIP interactions:1 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:N.65, B:N.382
NAG-NAG-BMA-FUL.14: 5 residues within 4Å:- Chain C: N.65, W.356, I.388
- Chain D: N.382, F.385
2 PLIP interactions:1 interactions with chain C, 1 interactions with chain D- Hydrogen bonds: C:N.65, D:N.382
- 4 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-D-mannopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG-BMA-MAN-MAN-MAN.4: 13 residues within 4Å:- Chain A: N.119, A.120, T.121, G.135
- Chain B: I.285, E.294, Q.310, I.311, N.312, R.313, Y.372, G.373, T.374
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.312, B:N.312, B:R.313, B:N.312, B:R.313
NAG-NAG-BMA-MAN-MAN-MAN.7: 13 residues within 4Å:- Chain B: N.119, A.120, T.121, G.135
- Chain C: I.285, E.294, Q.310, I.311, N.312, R.313, Y.372, G.373, T.374
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:N.312, C:N.312, C:R.313, C:N.312, C:R.313
NAG-NAG-BMA-MAN-MAN-MAN.16: 13 residues within 4Å:- Chain C: N.119, A.120, T.121, G.135
- Chain D: I.285, E.294, Q.310, I.311, N.312, R.313, Y.372, G.373, T.374
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:N.312, D:N.312, D:R.313, D:N.312, D:R.313
NAG-NAG-BMA-MAN-MAN-MAN.19: 13 residues within 4Å:- Chain A: I.285, E.294, Q.310, I.311, N.312, R.313, Y.372, G.373, T.374
- Chain D: N.119, A.120, T.121, G.135
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.312, A:N.312, A:R.313, A:N.312, A:R.313
- 2 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-FUC.6: 5 residues within 4Å:- Chain B: N.65, W.356, I.388
- Chain C: N.382, F.385
2 PLIP interactions:1 interactions with chain C, 1 interactions with chain B- Hydrogen bonds: C:N.382, B:N.65
NAG-NAG-BMA-FUC.18: 5 residues within 4Å:- Chain A: N.382, F.385
- Chain D: N.65, W.356, I.388
2 PLIP interactions:1 interactions with chain D, 1 interactions with chain A- Hydrogen bonds: D:N.65, A:N.382
- 4 x CA: CALCIUM ION(Non-covalent)
CA.9: 6 residues within 4Å:- Chain A: D.212, G.216, D.243, G.264, T.265, Q.266
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.212, A:G.216, A:G.264, A:Q.266, H2O.4
CA.11: 6 residues within 4Å:- Chain B: D.212, G.216, D.243, G.264, T.265, Q.266
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:D.212, B:G.216, B:G.264, B:Q.266
CA.21: 6 residues within 4Å:- Chain C: D.212, G.216, D.243, G.264, T.265, Q.266
5 PLIP interactions:4 interactions with chain C, 1 Ligand-Water interactions- Metal complexes: C:D.212, C:G.216, C:G.264, C:Q.266, H2O.9
CA.23: 6 residues within 4Å:- Chain D: D.212, G.216, D.243, G.264, T.265, Q.266
4 PLIP interactions:4 interactions with chain D- Metal complexes: D:D.212, D:G.216, D:G.264, D:Q.266
- 4 x DAN: 2-DEOXY-2,3-DEHYDRO-N-ACETYL-NEURAMINIC ACID(Non-covalent)
DAN.10: 16 residues within 4Å:- Chain A: R.37, E.38, D.70, R.71, W.97, S.98, I.141, R.143, E.146, A.165, E.195, E.196, R.211, N.213, R.290, Y.325
17 PLIP interactions:17 interactions with chain A- Hydrophobic interactions: A:R.143
- Hydrogen bonds: A:R.71, A:R.71, A:R.143, A:R.143, A:E.195, A:R.211, A:R.211, A:N.213, A:Y.325, A:Y.325
- Water bridges: A:R.37, A:E.146, A:R.290
- Salt bridges: A:R.37, A:R.211, A:R.290
DAN.12: 16 residues within 4Å:- Chain B: R.37, E.38, D.70, R.71, W.97, S.98, I.141, R.143, E.146, A.165, E.195, E.196, R.211, N.213, R.290, Y.325
14 PLIP interactions:14 interactions with chain B- Hydrophobic interactions: B:R.143
- Hydrogen bonds: B:R.71, B:R.71, B:R.143, B:R.143, B:E.195, B:R.211, B:R.211, B:N.213, B:Y.325, B:Y.325
- Salt bridges: B:R.37, B:R.211, B:R.290
DAN.22: 16 residues within 4Å:- Chain C: R.37, E.38, D.70, R.71, W.97, S.98, I.141, R.143, E.146, A.165, E.195, E.196, R.211, N.213, R.290, Y.325
18 PLIP interactions:18 interactions with chain C- Hydrophobic interactions: C:R.143
- Hydrogen bonds: C:R.71, C:R.71, C:R.143, C:R.143, C:E.195, C:R.211, C:R.211, C:N.213, C:Y.325, C:Y.325
- Water bridges: C:R.37, C:E.146, C:E.146, C:R.290
- Salt bridges: C:R.37, C:R.211, C:R.290
DAN.24: 16 residues within 4Å:- Chain D: R.37, E.38, D.70, R.71, W.97, S.98, I.141, R.143, E.146, A.165, E.195, E.196, R.211, N.213, R.290, Y.325
14 PLIP interactions:14 interactions with chain D- Hydrophobic interactions: D:R.143
- Hydrogen bonds: D:R.71, D:R.71, D:R.143, D:R.143, D:E.195, D:R.211, D:R.211, D:N.213, D:Y.325, D:Y.325
- Salt bridges: D:R.37, D:R.211, D:R.290
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jedrzejas, M.J. et al., Structures of aromatic inhibitors of influenza virus neuraminidase. Biochemistry (1995)
- Release Date
- 1995-03-31
- Peptides
- INFLUENZA A SUBTYPE N2 NEURAMINIDASE: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-tetramer
- Ligands
- 8 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- FUL: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-D-mannopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x CA: CALCIUM ION(Non-covalent)
- 4 x DAN: 2-DEOXY-2,3-DEHYDRO-N-ACETYL-NEURAMINIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jedrzejas, M.J. et al., Structures of aromatic inhibitors of influenza virus neuraminidase. Biochemistry (1995)
- Release Date
- 1995-03-31
- Peptides
- INFLUENZA A SUBTYPE N2 NEURAMINIDASE: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B